Imatinib for chronic myeloid leukaemia: a NICE mess
- 1 November 2001
- journal article
- Published by Elsevier in The Lancet
- Vol. 358 (9292) , 1478
- https://doi.org/10.1016/s0140-6736(01)06571-0
Abstract
No abstract availableKeywords
This publication has 4 references indexed in Scilit:
- Clinical Resistance to STI-571 Cancer Therapy Caused by BCR-ABL Gene Mutation or AmplificationScience, 2001
- Activity of a Specific Inhibitor of the BCR-ABL Tyrosine Kinase in the Blast Crisis of Chronic Myeloid Leukemia and Acute Lymphoblastic Leukemia with the Philadelphia ChromosomeNew England Journal of Medicine, 2001
- Efficacy and Safety of a Specific Inhibitor of the BCR-ABL Tyrosine Kinase in Chronic Myeloid LeukemiaNew England Journal of Medicine, 2001
- Tyrosine-kinase inhibition in treatment of chronic myeloid leukaemiaThe Lancet, 2000